Sponsor content
342 result(s) found, displaying 61 to 70
-
Cancellation by sponsorRequested by AstraZeneca Pty Ltd
-
Prescription medicine registrationActive ingredients: osimertinib mesilate.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort 0.5 mg/ml nebuliser suspension.
-
Australian Public Assessment Report (AusPAR)Lokelma (sodium zirconium cyclosilicate hydrate) was approved for the treatment of hyperkalaemia (high potassium levels in blood) in adult patients.
-
Australian Public Assessment Report (AusPAR)Enhertu (trastuzumab deruxtecan) was approved to treat adult patients with unresectable or metastatic HER2-low breast cancer.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 1mg.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules Budesonide Suspension for Inhalation 2ml: 0.5mg.
-
Australian Public Assessment Report (AusPAR)Sidapvia (dapagliflozin+sitagliptin), a new drug combination, has been approved to treat type 2 diabetes mellitus in adults, as an adjunct to diet and exercise to improve glycaemic control.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 0.5 mg/2 mL.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Pulmicort Respules budesonide 1 mg/2 mL.